申请人:IRONWOOD PHARMACEUTICALS, INC.
公开号:US20170298055A1
公开(公告)日:2017-10-19
The present patent application discloses at least the compounds according to Formula Ia and Formula Ib shown below, or pharmaceutically acceptable salts thereof,
wherein ring D, ring A, J
B
, n, J, R
C1
, R
C2
, Z
1
, Z
2
, W, X, Y
1
, Y
2
, J
F
and R
9
are as defined herein.